ADCYAP1 and breast carcinoma: As radiosensitivity varies from different cell cycles and the G2/M phase cells own the highest sensitivity to radiation (Jeong et al., 2017), these results also suggested the potential that PACAP38 may enhance the radiosensitivity of breast cancer cells by increasing cells arrested in G2/M phase.